IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 1 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,376 | -71.4% | 65,055 | -67.0% | 0.00% | -71.4% |
| Q2 2023 | $11,821 | +17.8% | 197,141 | -2.9% | 0.01% | +40.0% |
| Q1 2023 | $10,036 | -10.8% | 202,984 | +3.0% | 0.01% | 0.0% |
| Q4 2022 | $11,250 | -64.8% | 197,128 | +29234.5% | 0.01% | – |
| Q3 2022 | $32,000 | +10.3% | 672 | -13.4% | 0.00% | – |
| Q2 2022 | $29,000 | -12.1% | 776 | -30.0% | 0.00% | – |
| Q1 2022 | $33,000 | – | 1,108 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $24,560,000 | 4.02% |
| Rock Springs Capital Management LP | 2,292,285 | $97,583,000 | 2.13% |
| RTW INVESTMENTS, LP | 1,245,532 | $50,142,000 | 0.78% |
| Avidity Partners Management LP | 550,000 | $23,414,000 | 0.65% |
| Samsara BioCapital, LLC | 80,000 | $3,406,000 | 0.63% |
| Bain Capital Public Equity Management II, LLC | 300,871 | $12,808,000 | 0.53% |
| GENERAL ATLANTIC, L.P. | 950,000 | $40,442,000 | 0.47% |
| Baker Brothers Advisors | 2,520,730 | $107,307,000 | 0.46% |
| Perceptive Advisors | 400,000 | $17,028,000 | 0.22% |
| Pinz Capital Management, LP | 18,700 | $796,000 | 0.21% |